Nitric oxide-dependent CYP2B degradation is potentiated by a cytokine-regulated pathway and utilizes the immunoproteasome subunit LMP2. [electronic resource]
Producer: 20120926Description: 377-82 p. digitalISSN:- 1470-8728
- Animals
- Aryl Hydrocarbon Hydroxylases -- metabolism
- Cysteine Endopeptidases -- metabolism
- Cytochrome P-450 CYP2B1 -- metabolism
- Genes, Tumor Suppressor
- Hepatocytes -- drug effects
- In Vitro Techniques
- Interleukin-1 -- pharmacology
- Kinetics
- Male
- Metabolic Networks and Pathways
- Models, Biological
- NG-Nitroarginine Methyl Ester -- pharmacology
- Nitric Oxide -- metabolism
- Nitric Oxide Donors -- pharmacology
- Nitric Oxide Synthase Type II -- antagonists & inhibitors
- Nuclear Proteins
- Proteasome Endopeptidase Complex -- metabolism
- Proteasome Inhibitors
- Rats
- Rats, Inbred F344
- Steroid Hydroxylases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.